AWMNY
IOVA icon

Arcadia Wealth Management (New York)’s Iovance Biotherapeutics IOVA Stock Holding History

Arcadia Wealth Management (New York)’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.1K Hold
11,700
– – 0.02% 54
2025
Q4 		$31.9K Sell
11,700
-4,050
-26% -$9.37K 0.02% 55
2025
Q3 		$34.2K Hold
15,750
– – 0.02% 59
2025
Q2 		$27.1K Hold
15,750
– – 0.02% 52
2025
Q1 		$52.4K Hold
15,750
– – 0.04% 51
2024
Q4 		$117K Buy
+15,750
New +$146K 0.1% 45

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Arcadia Wealth Management (New York)'s IOVA Position: Q1 2026 in Review

Arcadia Wealth Management (New York) held its Iovance Biotherapeutics (IOVA) position steady in Q1 2026 at 11,700 shares worth $41.1K. The position accounts for 0.02% of the portfolio, ranked #54.

Arcadia Wealth Management (New York) first reported a position in IOVA in Q4 2024 and has held it in 6 quarters since. The position peaked at $117K in Q4 2024. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Arcadia Wealth Management (New York) held 11,700 shares of Iovance Biotherapeutics worth $41.1K as of Q1 2026.
  • Arcadia Wealth Management (New York) left its Iovance Biotherapeutics share count unchanged in Q1 2026.
  • Iovance Biotherapeutics made up 0.02% of Arcadia Wealth Management (New York)'s portfolio in Q1 2026, its #54 holding.
  • Arcadia Wealth Management (New York) first reported a position in Iovance Biotherapeutics in Q4 2024 and has held it in 6 quarters since.
  • Arcadia Wealth Management (New York)'s Iovance Biotherapeutics position peaked at $117K in Q4 2024.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Arcadia Wealth Management (New York)'s 13F filing for Q1 2026, filed 14 May 2026.